MSCV-human Erbb2-IRES-GFP Citations (2)

Originally described in: Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Vo BT, Li C, Morgan MA, Theurillat I, Finkelstein D, Wright S, Hyle J, Smith SM, Fan Y, Wang YD, Wu G, Orr BA, Northcott PA, Shilatifard A, Sherr CJ, Roussel MF Cell Rep. 2017 Mar 21;18(12):2907-2917. doi: 10.1016/j.celrep.2017.02.073. PubMed Journal

---

Articles Citing MSCV-human Erbb2-IRES-GFP

Articles
Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer. Erlangga Z, Wolff K, Poth T, Peltzer A, Nahnsen S, Spielberg S, Timrott K, Woller N, Kuhnel F, Manns MP, Saborowski A, Vogel A, Saborowski M. Cancers (Basel). 2019 Nov 29;11(12). pii: cancers11121904. doi: 10.3390/cancers11121904. PubMed
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families. Van Marcke C, Helaers R, De Leener A, Merhi A, Schoonjans CA, Ambroise J, Galant C, Delree P, Rothe F, Bar I, Khoury E, Brouillard P, Canon JL, Vuylsteke P, Machiels JP, Berliere M, Limaye N, Vikkula M, Duhoux FP. Breast Cancer Res. 2020 Apr 15;22(1):36. doi: 10.1186/s13058-020-01273-y. PubMed

If you have published an article using this material, please email us at to have your article added to this page.